Table 9

Clinicopathological parameters in relation to p53 expression in the tumour

	p53 expression		p Value
	<10%	⩾10%	p Value
ER, oestrogen receptor; p34^cdc2bn, p34^cdc2 expression in benign breast tissue; p34^cdc2TC, p34^cdc2 expression in tumour cytoplasm; p34^cdc2TN, p34^cdc2 expression in tumour nuclei; PR, progesterone receptor.
Age (years)
<50	28	11
⩾50	41	10	0.345
Menopausal
Pre	24	10
Post	43	11	0.338
T size
T1	34	8
T2	35	13	0.374
Grade
1	16	1
2	36	2
3	17	18	0.001
p34^cdc2TN
<10%	13	1
⩾10%	56	20	0.122
p34^cdc2TC
<10%	24	3
⩾10%	44	16	0.107
p34^cdc2bn
<10%	46	13
⩾10%	10	2	0.683
p21^WAF1
<6%	32	13
⩾6%	37	8	0.217
ER
Negative	18	17
Positive	48	4	0.001
PR
Negative	28	16
Positive	40	5	0.005
Relapse
No	58	21
Yes	11	–	0.052
Death
No	61	21
Yes	8	–	0.104

Expression of the cell cycle regulatory proteins p34^cdc2, p21^waf1, and p53 in node negative invasive ductal breast carcinoma

Pathology jobs